ClinicalTrials.Veeva

Menu
A

AZ Delta | Clinical Trial Center - Pneumology

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pembrolizumab
LY3298176
Tirzepatide
Selpercatinib
Alimta
Dostarlimab
Apixaban
Azacitidine
Elranatamab
Retatrutide

Parent organization

This site is a part of AZ Delta vzw

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

17 of 24 total trials

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

The main purpose of Part 1 of this study is to assess the efficacy and safety of 3 dose levels of Pirtobrutinib in participants with chronic lymphocy...

Enrolling
Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia
Drug: Pirtobrutinib
Locations recently updated

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Active, not recruiting
Atrial Fibrillation
Drug: Apixaban Placebo
Drug: Milvexian

The goal of this clinical trial is to learn how roginolisib works in combination with dostarlimab with or without docetaxel in adult patients with ad...

Enrolling
Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Advanced Non Squamous NSCLC
Drug: Docetaxel
Drug: Dostarlimab

The reason for this study is to see if the study drug, selpercatinib, compared to placebo is effective and safe in delaying cancer return in particip...

Active, not recruiting
Carcinoma, Non-Small-Cell Lung
Drug: Placebo
Drug: Selpercatinib

The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy...

Enrolling
Non-small Cell Lung Cancer
Drug: Relatlimab
Drug: Nivolumab

This study will compare how safe and effective sacituzumab tirumotecan is versus the treatment of physician's choice (TPC) in participants with advan...

Enrolling
Gastroesophageal Cancer
Drug: Rescue medication
Drug: Supportive care measures

The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who hav...

Enrolling
Atherosclerotic Cardiovascular Disease (ASCVD)
Elevated Lp(a)
Drug: Lepodisiran Sodium
Drug: Placebo

Researchers are looking for a better way to treat people who have advanced non-small cell lung cancer (NSCLC) with specific genetic changes called hu...

Enrolling
HER2 Mutation
Advanced Non-small Cell Lung Cancer
Drug: Cisplatin
Drug: Pembrolizumab

The purpose of this Phase 3 study is to evaluate the efficacy and safety of Luspatercept compared with placebo in subjects with myeloproliferative ne...

Active, not recruiting
Anemia
Myelofibrosis
Other: Placebo
Drug: ACE-536

The purpose of this study is to assess the efficacy and safety of co-formulated pembrolizumab/quavonlimab versus other treatments in participants wit...

Active, not recruiting
Colorectal Cancer
Biological: MK-4830
Biological: Pembrolizumab/Quavonlimab

Researchers are looking for a better way to treat people who have advanced non-small cell lung cancer (NSCLC), a group of lung cancers that have spre...

Active, not recruiting
EGFR Mutation
HER2 Mutation
Drug: BAY2927088_formulation A
Drug: BAY2927088_formulation B_2

The purpose of this study is to learn about the study medicine called elranatamab.This study aims to compare elranatamab to other medicines for the t...

Enrolling
Multiple Myeloma
Drug: Pomalidomide
Drug: Elotuzumab

The purpose of this study is to determine the safety and efficacy of belzutifan in combination with pembrolizumab and lenvatinib in multiple solid tu...

Active, not recruiting
Neoplasm Malignant
Drug: Pembrolizumab
Drug: Lenvatinib

PDC-LUNG-101 trial is an open-label, dose-escalation, phase I/II study to assess the safety, the tolerability, the immunogenicity and the preliminary...

Active, not recruiting
Non Small Cell Lung Cancer
Biological: PDC*lung01
Drug: Alimta Injectable Product

The main purpose of this study is to assess if olomorasib in combination with pembrolizumab is more effective than the pembrolizumab and placebo comb...

Enrolling
Carcinoma, Non-Small-Cell Lung
Drug: Olomorasib
Drug: Placebo

This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with severe hypertriglyceridemia (...

Active, not recruiting
Severe Hypertriglyceridemia
Drug: Plozasiran Injection
Drug: Placebo

The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent...

Enrolling
Atherosclerotic Cardiovascular Disease (ASCVD)
Chronic Kidney Disease (CKD)
Drug: Retatrutide
Drug: Placebo

Trial sponsors

Lilly logo
Merck Sharp & Dohme (MSD) logo
Abbott logo
Bayer logo
Arrowhead Pharmaceuticals logo
Bristol-Myers Squibb (BMS) logo
Celgene logo
D
Gilead Sciences logo
Janssen (J&J Innovative Medicine) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems